Isomorphic Labs, a unit of Alphabet Inc. established three years ago, was created to commercialize DeepMind's AI for drug discovery. AlphaFold, first released in 2018, has made strides in decoding protein shapes, a challenge often likened to mapping the human genome. The latest version of AlphaFold can model various molecular structures, including DNA and RNA, and predict their interactions.
Key takeaways:
- Google DeepMind has released a new version of AlphaFold, an AI tool for predicting protein structures, with potential to revolutionize medicine and biology research.
- The AI system could potentially create 'enormous commercial value' for DeepMind spinout Isomorphic Labs, potentially worth over $100 billion.
- Isomorphic Labs, a unit of Alphabet Inc., was created to commercialize DeepMind's AI for drug discovery.
- The latest version of AlphaFold can model a range of molecular structures, including DNA and RNA, and predict their interactions.